Seliger B - Search Results

1

Antigen-processing machinery breakdown and tumor growth.

Seliger B, Maeurer MJ, Ferrone S. Seliger B, et al. Immunol Today. 2000 Sep;21(9):455-64. doi: 10.1016/s0167-5699(00)01692-3. Immunol Today. 2000. PMID: 10953098 Review.

2

Oncogene transformation can induce tolerogenicity in murine macrophages after down-regulation of immunogenicity without altering major histocompatibility complex antigen expression.

Wottge HU, Eckstein V, Seliger B, Müller-Ruchholtz W. Wottge HU, et al. Among authors: seliger b. Scand J Immunol. 1993 Jul;38(1):49-56. doi: 10.1111/j.1365-3083.1993.tb01693.x. Scand J Immunol. 1993. PMID: 8327859

3

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.

Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH, et al. Bernhard H, et al. Among authors: seliger b. Int J Cancer. 1994 Dec 15;59(6):837-42. doi: 10.1002/ijc.2910590621. Int J Cancer. 1994. PMID: 7989126

4

Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.

Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B. Meissner M, et al. Among authors: seliger b. Br J Dermatol. 2008 May;158(5):930-40. doi: 10.1111/j.1365-2133.2008.08465.x. Epub 2008 Feb 16. Br J Dermatol. 2008. PMID: 18284388

5

Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.

Li J, Schuler-Thurner B, Schuler G, Huber C, Seliger B. Li J, et al. Among authors: seliger b. Int Immunol. 2001 Dec;13(12):1515-23. doi: 10.1093/intimm/13.12.1515. Int Immunol. 2001. PMID: 11717192

6

c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Tudor CS, Dawson CW, Eckhardt J, Niedobitek G, Büttner AC, Seliger B, Hartmann A, Buettner M. Tudor CS, et al. Among authors: seliger b. Br J Cancer. 2012 Jun 5;106(12):1980-8. doi: 10.1038/bjc.2012.197. Epub 2012 May 15. Br J Cancer. 2012. PMID: 22588558 Free PMC article.

7

Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Seliger B, et al. Cancer Res. 2001 Feb 1;61(3):1095-9. Cancer Res. 2001. PMID: 11221838

8

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.

Seliger B, Rongcun Y, Atkins D, Hammers S, Huber C, Störkel S, Kiessling R. Seliger B, et al. Int J Cancer. 2000 Aug 1;87(3):349-59. Int J Cancer. 2000. PMID: 10897039

9

Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent.

Jung D, Hilmes C, Knuth A, Jaeger E, Huber C, Seliger B. Jung D, et al. Among authors: seliger b. Scand J Immunol. 1999 Sep;50(3):242-9. doi: 10.1046/j.1365-3083.1999.00588.x. Scand J Immunol. 1999. PMID: 10447932

10

Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.

Kallfelz M, Jung D, Hilmes C, Knuth A, Jaeger E, Huber C, Seliger B. Kallfelz M, et al. Among authors: seliger b. Int J Cancer. 1999 Mar 31;81(1):125-33. doi: 10.1002/(sici)1097-0215(19990331)81:1<125::aid-ijc21>3.0.co;2-2. Int J Cancer. 1999. PMID: 10077163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results